Variable potentiation of analgesic anti- inflammatory activity of diclofenac by two medicinal plants rubia cordifolia and cassia fistula in wistar albino rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20170942Keywords:
Analgesic - antiinflammatory, Diclofenac, Cassia fistula (CF), Potentiation, Rubia cardifolia (RC)Abstract
Background: NSAIDS are commonly prescribed drugs in clinical practice. However, their usage is limited by their toxicity profile and research continues for an alternative therapy with higher efficacy and safety. Various plant preparations found to be safe and effective are emerging, but their interactions with synthetic drugs are not much known.
Methods: Wistar rats were divided in to four groups of six animals each Rubia cordifolia (RC) root preparation and casissia fistula (CF) leaf preparation were studied with sub anti-inflammatory dose of diclofenac in various analgesic, acute and subacute inflammatory models and test results variables were expressed in mean reaction time, paw edema volume and granuloma weight respectively.
Results: Various test results were tabulated, statistically analysed and significance was calculated at P value <0.5. Eddy’s hot plate model did not show any significant change, but carrageenan induced paw edema model and cotton pellet induced granuloma model showed comparable decrease in paw edema volume and granuloma dry weight.
Conclusions: Diclofenac, a standard analgesic and anti –inflammatory was not potentiated in pain model but it was potentiated in carrageenan and cotton pellet granuloma models in a variable manner. CF potentiates acute anti-inflammatory action, whereas RC potentiates subacute anti-inflammatory actions of diclofenac.
References
Rang HP, Dale MN, Ritter JM, Henderson G. Analgesic Drugs. In: Rang and Dale’s Pharmacology. 7th edition. Edinburgh: Elsevier Churchill Livingstone; 2012:503.
Tramer MR, Moore RA, Reynolds DJ, MCQuay HJ. Quantative estimation of rare adverse events which follow a biological progression: a new model to chronic NSAID use. Pain. 2000;85(1-2):169-82.
Tamblyn R, Brkson L, Dauphinee WD. Unnecessary prescribing of NSAIDs and the management of NSAID- related gastropathy in medical practice. Annals of Internal Medicine. 1997;127(6):429-38.
Sengupta R, Sheorey SD, Hinge MA. Analgesic and anti-inflammatory Plants: An Updated Review. International Journal of Pharmaceutical sciences Review and Research. 2012;12(2):114-19.
Kasture SB, Kasture VS, Chopde CT. Anti0inflammatory a ctivity of Rubia Cordofolia roots. Jouranal of Natural Remedies. 2001;(1/2):111-15.
Joharapurkar AA, Deode NM, Zambad SP, Umathe SN. Immunomodulatory activity of Alchoholic extract of Rubia Cordiofolia Linn. Indian Drugs. 2003;40(3):179-81.
Neelam C, Ranjan B, Komal S, Noothan C. Review on Cassis Fistula. International Journal of Research in Ayurveda and pharmacy. 2011;2(2):426-30.
Danish M, Singh P, Mishra G, Srivastava S, Jha KK, Khosa RL. Cassia fistula Linn. (Amulthus-)-An important Medicinal plant: A review of its Traditional uses, phytochemistry and pharmacological properties. Journal of Natural Product and plant Resources. 2011;1(1):101-18.
Wasu SJ, Muley BP. Hepatoprotective effect of Cassia Fistula Linn. Ethnobotanical Leaflets. 2009;13:910-16.
Wong S, Garadocki JF. Anti-inflammatory and anti- arthritic evaluation of acetaminophen and its potentiation of tolmetin. J Pharmacol. Exp Ther. 1983;226:626-32.
